Ribbon Biolabs
Latest round
- Series A
Last raised
- Jan 2022
Total raised
- $20M
Investors
- 4
About Ribbon Biolabs
Based in Vienna, Austria, and founded in 2018, by co-founders Harold de Vladar and Wladimir Labeikovsky, Ribbon Biolabs GmbH, aka Ribbon Biolabs operates as a developer of automated synthesis of long DNA molecules to enable innovation in biotechnology. The company provides an in-house synthesis platform InfiniSynth, a technology involving machine learning and robotic automation for the enzymatic assembly of long DNA molecules. Ribbon Biolabs also offer FullGenes, which produces and delivers a synthetic linear double-stranded DNA molecule according to a customer specification and uses combinatorial optimization algorithms to guide the automated enzymatic assembly of DNA. The platform applies robotic adaptive control in a sequence-specific manner to ensure the highest accuracy of the synthetic DNA. The company's services offer deoxyribonucleic acid to create genomes, high-throughput libraries, innovative deoxyribonucleic acid-based products, store data, and more. In addition, the company provides researchers and companies with the flexibility to focus on libraries of deoxyribonucleic acids with lengths up to base pairs.
Who invested in Ribbon Biolabs
4 investors across 2 rounds
See all investors in Ribbon Biolabs
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Ribbon Biolabs
Who invested in Ribbon Biolabs?
Ribbon Biolabs has 4 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Ribbon Biolabs raised?
Ribbon Biolabs has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Ribbon Biolabs last raise money?
Ribbon Biolabs's most recent round on record is a Series A, in Jan 2022.
What does Ribbon Biolabs do?
Based in Vienna, Austria, and founded in 2018, by co-founders Harold de Vladar and Wladimir Labeikovsky, Ribbon Biolabs GmbH, aka Ribbon Biolabs operates as a developer of automated synthesis of long DNA molecules to enable innovation in biotechnology.
Where is Ribbon Biolabs headquartered?
Ribbon Biolabs is headquartered in Vienna, Austria.
Which VCs invest in companies like Ribbon Biolabs?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at Ribbon Biolabs's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Ribbon Biolabs? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.